300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Social Network
Blockchain
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Nigeria
Isle of Man
Pakistan
Sweden
Romania
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Cameroon
Oman
India
Colombia
Australia
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Germany
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
United Kingdom
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
Peru
Slovenia
San Marino
Ukraine
Ireland
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Asia (June 2026)

The most active venture capital funds and angel investors investing in Asia Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Asia Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Qiming Venture Partners
VC Fund
62 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $5M–$142M
HSG
VC Fund
43 China, United States, Hong Kong Series A, Series B, Series C Health Care, Biotechnology, Software $4.4M–$214M
BioVenture
VC Fund
37 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $1.9M–$73M
Lilly Asia Ventures
VC Fund
31 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$259M
Med-Fine Capital
VC Fund
29 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $2.8M–$60M
Kaitai Capital
VC Fund
26 China, United States, Singapore Series A, Series B, Angel Biotechnology, Health Care, Pharmaceutical $425k–$57M
Frees Fund
VC Fund
25 China, United States, Singapore Series A, Seed, Angel Artificial Intelligence, Health Care, Biotechnology $425k–$35M
Matrix Partners China
VC Fund
25 China, United States, Hong Kong Series A, Series B, Seed Health Care, Biotechnology, Software $1.4M–$108M
IDG Capital
VC Fund
22 China, United States, India Series A, Series B, Series C Software, Internet, E-Commerce $3M–$200M
Sherpa Healthcare Partners
VC Fund
22 China, United States, Kenya Series A, Series B, Series C Biotechnology, Health Care, Medical $2.8M–$156M
Legend Capital
VC Fund
21 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $2.8M–$200M
Seeds Capital
VC Fund
21 Singapore, United States, Hong Kong Seed, Series A Software, Biotechnology, Health Care $767k–$24M
Northern Light Venture Capital
VC Fund
20 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology $1.3M–$100M
Mitsubishi UFJ Capital
VC Fund
20 Japan, United States, Singapore Series A, Series B Information Technology, Software, Health Care $2M–$369M
Linear Capital
VC Fund
19 China, Singapore, Switzerland Seed, Angel, Series A Artificial Intelligence, Software, Manufacturing $1.4M–$122M
Hillhouse Investment
VC Fund
18 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$230M
UntroD Capital
VC Fund
18 Japan, Singapore, Austria Seed, Series A Manufacturing, Biotechnology, Medical $2.1M–$241M
CDH Investments
VC Fund
18 China, United States, Canada Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $7.3M–$300M
TF Capital
VC Fund
18 China, United States Series A, Series B, Seed Biotechnology, Health Care, Medical $5.7M–$120M
Highlight Capital
VC Fund
17 China, United States, Portugal Series A, Series B, Seed Health Care, Medical, Biotechnology $2.8M–$73M
Green Pine Capital Partners
VC Fund
16 China, United States, Canada Series A, Series B, Angel Artificial Intelligence, Software, Biotechnology $425k–$150M
Osaka University Venture Capital
VC Fund
16 Japan Seed, Series A Biotechnology, Health Care, Manufacturing $7.1M–$142M
Fast Track Initiative, Inc.
VC Fund
16 Japan, United States, United Kingdom Series A, Seed, Series B Health Care, Biotechnology, Medical $1.1M–$184M
Delian Capital
VC Fund
16 China, United States, France Series A, Seed, Series B Biotechnology, Manufacturing, Health Care $199k–$50M
SMBC Venture Capital
VC Fund
16 Japan, United States, Singapore Series A, Series B Information Technology, Health Care, Software $4.5M–$425M
Shenzhen Capital Group
VC Fund
16 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, Software $1.4M–$142M
Puhua Capital
VC Fund
15 China, United Kingdom, United States Series A, Series B, Seed Health Care, Medical, Manufacturing $1.4M–$100M
CD Capital
VC Fund
15 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.4M–$34M
ANRI
VC Fund
15 Japan, United States, India Seed, Series A Software, Health Care, Information Technology $628k–$624M
Prox Ventures
VC Fund
14 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
Gaorong Capital
VC Fund
14 China, United States, Hong Kong Series A, Series B, Seed Information Technology, Software, Artificial Intelligence $2.8M–$110M
Baidu Ventures
VC Fund
14 China, United States, Singapore Series A, Seed, Series B Artificial Intelligence, Health Care, Biotechnology $1.4M–$145M
SDIC Venture Capital
VC Fund
14 China, United States, Hong Kong Series B, Series A, Series C Manufacturing, Biotechnology, Electronics $2.8M–$170M
Cowin Capital
VC Fund
14 China, Hong Kong, United States Series A, Series B, Seed Manufacturing, Health Care, Biotechnology $1.4M–$50M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
13 Japan, United States, India Seed, Series A Health Care, Biotechnology, Medical $3.1M–$85M
BioTrack Capital
VC Fund
13 China, United States, Singapore Series A, Series B, Seed Biotechnology, Health Care, Medical $3M–$168M
K2VC
VC Fund
12 China, United States, Japan Series A, Seed, Angel E-Commerce, Manufacturing, Biotechnology $425k–$24M
Longpan Investment
VC Fund
12 China, United States, Cayman Islands Series A, Series B, Seed Health Care, Medical, Biotechnology $14M–$60M
Keio Innovation Initiative
VC Fund
12 Japan, United Kingdom Series A, Seed Health Care, Medical, Biotechnology $1.5M–$213M
Legend Star
VC Fund
12 China, United States, France Series A, Seed, Angel Health Care, Medical, Biotechnology $425k–$52M
Cowin Venture
VC Fund
12 China, United States, Hong Kong Series A, Angel, Series B Health Care, Medical, Biotechnology $425k–$257M
Pan-Lin Capital
VC Fund
12 China, United States, Canada Seed, Series A, Series B Health Care, Biotechnology, Medical $1k–$57M
Addor Capital
VC Fund
12 China, Hong Kong, Singapore Series A, Series B Manufacturing, Semiconductor, Electronics $1.4M–$43M
ZSVC
VC Fund
11 China, United States, India Series A, Seed, Series B Manufacturing, Medical, Health Care $1.4M–$85M
LYFE Capital
VC Fund
11 China, United States, France Series B, Series A, Series C Biotechnology, Health Care, Medical $6.5M–$148M
ZhenFund
VC Fund
11 China, United States, Singapore Series A, Seed, Angel Artificial Intelligence, Software, E-Commerce $425k–$28M
JAFCO
VC Fund
11 Japan, United States, Israel Series A, Series B Information Technology, Software, Artificial Intelligence $2.7M–$298M
Oriental Fortune Capital
VC Fund
11 China, United States Series A, Series B, Seed Software, Manufacturing, Information Technology $1.4M–$100M
Shunwei Capital
VC Fund
11 China, United States, India Series A, Series B, Series C Manufacturing, Software, Internet $1.4M–$130M
Sinovation Ventures
VC Fund
11 China, United States, Hong Kong Series A, Seed, Series B Software, Artificial Intelligence, Internet $1M–$110M
Access all 50 investors in Asia Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 62 investments in Asia Biotech startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 740
  • Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $887M in 2023

Portfolio highlights

  • Plum — Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.
  • Bytelumio — Bytelumio creates advanced all-optical networks that deliver high-speed connections of 800G and 1.6T for data centers.
  • Guangjing Energy — Guangjing Energy is a perovskite solar cell module developer, dedicated to the R&D of long-life large-area perovskite solar cell modules.
Show all investments...

HSG
VC Fund · Beijing, Beijing, China · 43 investments in Asia Biotech startups, 10 in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 751
  • Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
  • Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
  • Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 37 investments in Asia Biotech startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 165
  • Round size: Seed $7.1M–$20M; Series A $1.9M–$43M; Series B $3M–$73M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
  • Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 31 investments in Asia Biotech startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 212
  • Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
  • Ronovo Surgical — Founded in 2019 and headquartered in Shanghai, Ronovo Surgical is founded by industry veterans from global leaders in surgical and industrial robotics, such as Intuitive Surgical, Johnson & Johnson, Medtronic and KUKA. Aiming to transform how surgery is performed in China, Ronovo is leveraging robust R&D capabilities and strategicpartnerships globally to accelerate the development of a broad portfolio of MIS and digital surgery solutions that exemplifies the core themes of simplicity, precision, and intelligence.
  • Alebund Pharmaceuticals — Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 29 investments in Asia Biotech startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 78
  • Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $69M in 2019

Portfolio highlights

  • Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
  • Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Show all investments...

Kaitai Capital
VC Fund · Hangzhou, Zhejiang, China · 26 investments in Asia Biotech startups

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 123
  • Round size: Angel $425k–$14M; Series A $1.4M–$35M; Series B $4.3M–$57M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Primelink Bio — Primelink Bio is a Biotechnology firm that is working to to develop next generation of drug delivery systems.
  • Huaboron Neutron — Huaboron Neutron is a biotechnology company that develops boron drugs and boron neutron capture therapy devices for the diagnosis of malignant cancers.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show all investments...

Frees Fund
VC Fund · Beijing, Beijing, China · 25 investments in Asia Biotech startups

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 199
  • Round size: Seed $1.4M–$14M; Angel $425k–$17M; Series A $1.4M–$35M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
  • Neurodome — Neurodome is a manufacturer of non-invasive deep brain nerve modulation technology. It focuses on the research and development of non-invasive deep brain nerve modulation products.
  • Pulin Technology — Pulin Technology provides tools and materials for creating nanoimprints and contributes to the study and advancement of fundamental technologies.
Show all investments...

Matrix Partners China
VC Fund · Beijing, Beijing, China · 25 investments in Asia Biotech startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 440
  • Round size: Seed $1.4M–$32M; Series A $2.8M–$60M; Series B $9.5M–$108M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
  • Ambilight — Ambilight focuses on smart and flexible thin-film innovation and manufacturing. The company has multiple international leading technologies, ranging from material synthesis, manufacturing to product design. Two innovation centers, located in Shenzhen and the US, are working strategically with multiple Fortune Global 500 companies.
  • Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Show all investments...

IDG Capital
VC Fund · Beijing, Beijing, China · 22 investments in Asia Biotech startups

IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 725
  • Round size: Series A $3M–$112M; Series B $7.4M–$142M; Series C $15M–$200M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • RootCloud — ROOTCLOUD is an IIoT platform provider, which has created IIoT platforms that have satisfied the needs of customers worldwide.
  • Yuanfudao — Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and largepool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.
  • Bodor Laser — Bodor Laser is a manufacturing company engaged in the R&D, production, and marketing of laser cutting machines. The company's laser products are high powered and range from 25000W, 30000W, 40000W, and 22000W laser cutting machines. The company is also the highest ranked in 10kW+ laser cutting machine sales volume.
Show all investments...

Sherpa Healthcare Partners
VC Fund · Beijing, Beijing, China · 22 investments in Asia Biotech startups

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Kenya

Investor stats

  • Total investments: 99
  • Round size: Series A $2.8M–$50M; Series B $14M–$100M; Series C $12M–$156M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
  • Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
  • Biortus — Wuxi Biortus Biosciences is an innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery.To help our clients achieve their drug discovery goals, we have established five world-class research platforms. These are Recombinant Protein Production, Structural Biology (X-rayCrystallography and Cryo-EM), In Vitro Assays and Screening, Medicinal Chemistry, and Process Development. Through the years, our R&D team has developed a number of practical and innovative techniques of which some have already been granted patent.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Legend Capital
VC Fund · Beijing, Beijing, China · 21 investments in Asia Biotech startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 389
  • Round size: Series A $2.8M–$94M; Series B $12M–$113M; Series C $14M–$200M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • ZStack — ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.
  • PhiSkin — PhiSkin operates as a skin and laser clinic. The company is based in China.
  • Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
Show all investments...

Seeds Capital
VC Fund · Singapore, Central Region, Singapore · 21 investments in Asia Biotech startups

Catalysing smart monies into Singapore-based, early-stage technology startups.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Singapore, United States, Hong Kong

Investor stats

  • Total investments: 130
  • Round size: Seed $767k–$6M; Series A $3.5M–$24M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Biorithm — Biorithm is a company that creates obstetrics remote monitoring platforms and point-of-care devices for pregnant and postnatal patients. The company combines proprietary data analytics software and medical-grade wearables to monitor a wide range of pregnancy vital data such as fetal heart rate, uterine contractions, and maternal heart rate,allowing clinicians to gain new insights into the health of the mother and baby while also providing expecting mothers with better access to healthcare, convenience, and more information about their pregnancy to identify early signs of complications.
  • Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative
  • XSQUARE Technologies — XSQUARE sets out to optimise and reshape the warehousing scene by developing a suite of proprietary AGVs and best-in-breed warehouse automation solutions.
Show all investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 20 investments in Asia Biotech startups

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 242
  • Round size: Seed $1.3M–$100M; Series A $4.3M–$40M; Series B $11M–$62M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
  • Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
  • Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
Show all investments...

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 20 investments in Asia Biotech startups

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 501
  • Round size: Series A $2M–$113M; Series B $5.7M–$369M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • Diggle — DIGGLE is a service that provides fundamental management accounting management on the cloud called fraud management. It is possible to reduce the mistakes and man-hours of the fraud management task and easily carry out the fraud management task even if it is not an expert in finance or accounting.DIGGLE covers budget creation work and budgetrecord comparison work, especially in the foreman management work. In the budget creation work, the KPI and the budget are automatically created by inputting the target numerical value to the preset parameters utilizing the budget generator function, while the forecast contrasting work is made up of the financial information, non-financial information It is easy to calculate by simply entering the numerical value, and it is possible to carry out calculation of the forecast contrast.
  • Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
  • Japan Culture and Technology — Japan Culture and Technology assists artists and craftspeople in expanding their activities by providing IT support.
Show all investments...

Linear Capital
VC Fund · Shanghai, Shanghai, China · 19 investments in Asia Biotech startups

Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Manufacturing
  • Stage:Seed, Angel, Series A
  • Geography: China, Singapore, Switzerland

Investor stats

  • Total investments: 85
  • Round size: Seed $1.4M–$120M; Angel $1.4M–$122M; Series A $5.7M–$50M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $500M in 2021

Portfolio highlights

  • NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
  • Juehua Medical — Juehua Medical is a medical technology company focusing on the field of visual health.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 18 investments in Asia Biotech startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$142M; Series B $14M–$230M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

UntroD Capital
VC Fund · Sumida, Tokyo, Japan · 18 investments in Asia Biotech startups

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, Singapore, Austria

Investor stats

  • Total investments: 124
  • Round size: Seed $3.2M–$43M; Series A $2.1M–$241M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
  • Illumi Medical — Illumi Medical is a manufacturing company that produces medical equipment and devices for the healthcare sector.
  • Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Show all investments...

CDH Investments
VC Fund · Kowloon City, Kowloon, Hong Kong · 18 investments in Asia Biotech startups

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 272
  • Round size: Series A $7.3M–$198M; Series B $14M–$142M; Series C $14M–$300M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
  • Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
  • ReviR Therapeutics — ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Show all investments...

TF Capital
VC Fund · Pudong, Shandong, China · 18 investments in Asia Biotech startups, 7 in the past 12 months

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 62
  • Round size: Seed $10M–$28M; Series A $5.7M–$120M; Series B $11M–$110M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Skild AI — Building general purpose robotic intelligence
  • QL Biopharma — QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
  • Vivatides Therapeutics — Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 17 investments in Asia Biotech startups, 36 in the past 12 months

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Portugal

Investor stats

  • Total investments: 154
  • Round size: Seed $8.5M–$73M; Series A $2.8M–$73M; Series B $7.6M–$70M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $563M in 2021

Portfolio highlights

  • Yixiu — Yixiu provides sleep health products such as smart wearables, smart home sleep scene hardware, sleep data analysis platforms, energy management apps, and more.
  • Yushi Space — Yushi Space is a liquid rocket developer that focuses on the development and manufacture of large-capacity, low-cost and rapidly reusable liquid rockets.
  • PoShell Robotics — PoShell Robotics is a general-purpose home robot, aiming to create a home-friendly and structurally stable robot.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Green Pine Capital Partners
VC Fund · Shenzhen, Guangdong, China · 16 investments in Asia Biotech startups

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 180
  • Round size: Angel $425k–$2.9M; Series A $1.4M–$100M; Series B $9.9M–$150M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $138M in 2019

Portfolio highlights

  • Toramon — Toramon is dedicated to providing innovative Artificial Intelligence sensing solutions of high performance and low cost for ADAS and autonomous vehicles. Adhering to the development vision of "making driving safer", the company applies the world's first human vision bionic technology to autonomous vehicles, which can effectivelyreduce traffic accidents. This core technology breaks through the capability bottleneck of the existing on-board environmental sensors. In extreme scenarios such as special-shaped object recognition, all-round collision prediction, and vehicle close-up jamming, it shows better scene adaptability and reliability than existing artificial intelligence algorithms. Since this technology does not rely on big data training, it will help greatly reduce the cost of mass production and maintenance of autonomous driving systems, and can effectively promote the industrialization of autonomous driving technology.
  • MindRank AI — MindRank AI is a developer of proprietary end-to-end AI-driven drug discovery platform (Molecule Pro™).
  • Ruitai Biotechnology — Ruitai is a developer for ophthalmic regenerative medicine, specialising in the R&D and sale of repair materials and medical device products
Show all investments...

Osaka University Venture Capital
VC Fund · Osaka, Osaka, Japan · 16 investments in Asia Biotech startups

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 79
  • Round size: Seed $7.1M–$99M; Series A $16M–$142M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
  • Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
  • Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Show all investments...

Fast Track Initiative, Inc.
VC Fund · Hongo, Tokyo, Japan · 16 investments in Asia Biotech startups

Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 77
  • Round size: Seed $1.2M–$117M; Series A $1.1M–$142M; Series B $7.7M–$184M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $1.1B in 2021

Portfolio highlights

  • Global Vascular
  • Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Show all investments...

Delian Capital
VC Fund · Beijing, Beijing, China · 16 investments in Asia Biotech startups

Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, France

Investor stats

  • Total investments: 93
  • Round size: Seed $199k–$50M; Series A $1.6M–$17M; Series B $9.9M–$29M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Rigerna — Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues.
  • Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
  • MingShi Brain-Computer Interaction — Mindtrix (明视脑机) develops brain–computer‑interface technology focused on reconstructing visual information and neural signals from the brain, primarily for visual‑reconstruction and implantable‑BCI applications. It conducts research and builds systems to decode brain‑wave patterns and translate them into machine‑interpretable outputs, aiming atadvanced neurotechnology and human–machine interfaces. The company also works on underlying hardware and software platforms that support high‑precision neural data acquisition, processing, and real‑time feedback loops.
Show all investments...

SMBC Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 16 investments in Asia Biotech startups

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Show more...

Investment focus

  • Industry: Information Technology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 513
  • Round size: Series A $4.5M–$170M; Series B $5.7M–$425M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Letara — Letara operates a space technology platform with the intention to serve a logistics network covering the solar system. The company produces hybrid propulsion engines for small spacecraft, promoting groundbreaking advances in space propulsion with high thrust, safe, and inexpensive propulsion system technology.
  • Pragtech — Pragtech develops and operates parking lot service software that helps to eliminate payment congestion and reduce operating costs.
  • Metro Weather — Metroweather is a venture from Kyoto University that develops a high-performance Doppler lidar that measures the direction and speed of wind several tens of kilometers away from minute movements of fine particles in the atmosphere. We aim to contribute to the safety of the sky by completing a three-dimensional wind map, which has never beenrealized,based on years of research at the Kyoto University Research Institute for Sustainable Areas.
Show all investments...

Shenzhen Capital Group
VC Fund · Shenzhen, Guangdong, China · 16 investments in Asia Biotech startups

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 408
  • Round size: Series A $1.4M–$142M; Series B $13M–$142M; Series C $4.3M–$142M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • MoleculeMind — MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform.
  • Biosun Pharma — Biosun Pharma is an innovative biopharmaceutical company that specializes in the production of drugs for tumors, self-immune diseases, and inflammatory diseases.
Show all investments...

Puhua Capital
VC Fund · Hangzhou, Zhejiang, China · 15 investments in Asia Biotech startups

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Show more...

Investment focus

  • Industry: Health Care, Medical, Manufacturing
  • Stage:Series A, Series B, Seed
  • Geography: China, United Kingdom, United States

Investor stats

  • Total investments: 202
  • Round size: Seed $1.4M–$29M; Series A $1.4M–$41M; Series B $2.8M–$100M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • SafeCare — SafeCare is an innovative therapeutics company that focuses on the technology realization, product development, and clinical implementation of new applications of electric field therapy.
  • Yitang Technology — Yitang Technology is a developer specializing in high-speed and high-precision placement machines. The company is dedicated to the research and development (R&D) of these advanced machines, as well as the industrialization of intelligent production line solutions.
  • Garen Semiconductor — Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide).
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 15 investments in Asia Biotech startups

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 69
  • Round size: Seed $1.4M–$14M; Series A $1.4M–$32M; Series B $7.1M–$34M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Pipi Bear
  • Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Show all investments...

ANRI
VC Fund · Tokyo, Tokyo, Japan · 15 investments in Asia Biotech startups

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 240
  • Round size: Seed $628k–$92M; Series A $6.1M–$624M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely still investing — raised $102M in 2022

Portfolio highlights

  • MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
  • Chaintope — Chaintope is specializes in blockchain technology with a focus for FinTech and non-FinTech sectors.
  • xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 14 investments in Asia Biotech startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • DotBio — DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
  • Coastar Therapeutics — Coastar Therapeutics develops an erythrocyte enveloped virus delivery technology platform to perform repeated virus dosing. It evades recognition and attack by the immune system to address the challenges of systemic and repeated administration of drug therapies. Coastar's process technology and “red blood cell membranes only” enable thecompany to overcome the challenges of mass production and standardization, and has cost advantages. The company's first product targets oncolytic viruses and is developing ELCV solutions for other therapies.The company was founded in 2017 and is based in San Diego, CAlifornia.
  • Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Gaorong Capital
VC Fund · Wangjing, Beijing, China · 14 investments in Asia Biotech startups

Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 261
  • Round size: Seed $2.8M–$57M; Series A $2.8M–$73M; Series B $14M–$110M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2020

Portfolio highlights

  • PDD Holdings — Pinduoduo is an e-commerce platform allowing users to participate in group buying deals, mostly through Tencent’s Wechat app. The company was founded in 2015 and is based in Shanghai, China.
  • AIpark — AIpark is provides a smart parking management solution. AIPark upgrades traditional parking spaces into “smarter ones” for local governments or businesses by leveraging on its in-house visual recognition technologies.
  • XYZ Robotics — XYZ Robotics develops AI-enabled robotic perception and manipulation technology for logistics and manufacturing automation. The company develops autonomous robotic solutions for put wall sorting and goods-to-person picking. Its robot sorts unorganized, random warehouse goods into groups of customer orders. The solution embodies its strength in deeplearning and robotics.
Show all investments...

Baidu Ventures
VC Fund · Beijing, Beijing, China · 14 investments in Asia Biotech startups

Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 207
  • Round size: Seed $1.9M–$14M; Series A $1.4M–$42M; Series B $8M–$145M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Sondit — Sondit specializes in R&D and manufacturing of civilian radar systems. It includes intelligent transportation, intelligent security, vehicle-road coordination, and other fields. It engaged in traffic information monitoring and urban traffic management in the field of the intelligent transportation industry.
  • Enze Kangtai — Exosome products, reagents, services, and platform capabilities.
  • Fastlane — We take innovative brands global. Fastlane is a full-service D2C solutions provider that assists enterprises with brand development, business infrastructure, and sales creation/growth in European, North American and Asian markets. We offer a superior one-stop solution, with expertise in go-to-market strategy, traditional and digital marketing,PR, logistics, e-commerce, sales, and platform development. We work with companies big and small, and our custom-tailored solutions range in scope from basic consulting services to 360° turnkey operations.
Show all investments...

SDIC Venture Capital
VC Fund · Xicheng, Hebei, China · 14 investments in Asia Biotech startups, 11 in the past 12 months

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Electronics
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 152
  • Round size: Series A $8.5M–$99M; Series B $2.8M–$170M; Series C $14M–$75M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Parylene — Parylene is a provider of protective coating application solutions
  • Alnan Aluminium — Alnan Aluminium is an industrial company that offers aluminum products, fabrication, and non-ferrous metal smelting services.
  • United Optics Technology — United Optoelectronics Technology specializes in the spot supply of optical components, laser optical components, image lenses, optomechanical components, and optoelectronic instruments.
Show all investments...

Cowin Capital
VC Fund · Shenzhen, Guangdong, China · 14 investments in Asia Biotech startups

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 282
  • Round size: Seed $1.4M–$20M; Series A $4.3M–$43M; Series B $2.8M–$50M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $75M in 2014

Portfolio highlights

  • Hohem — Hohem is a world-leading brand dedicated to AI tracking gimbals for video shooting, providing consumer and professional stabilizers for smartphones and cameras.
  • AnDiConBio — developer of respiratory anti-infection drugs, offering high-potential, low-risk products like new anti-influenza and oral anti-new coronavirus.
  • Hengpujiguang — Hengpujiguang is a developer of 3D printing metal machine.
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 13 investments in Asia Biotech startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 175
  • Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
  • Metcela — Cells hold endless possibilities. Through science, we will unlock these potentials and harness them to improve the lives of patients worldwide.
  • Startbahn — Startbahn develops Startrail, a sustainable and scalable blockchain infrastructure that assures the reliability, authenticity, and traceability of artworks.
Show all investments...

BioTrack Capital
VC Fund · Shanghai, Shanghai, China · 13 investments in Asia Biotech startups

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 84
  • Round size: Seed $14M–$168M; Series A $3M–$43M; Series B $14M–$150M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
  • Shenluo Medical — Shenluo Medical manufactures functional neural implantable medical devices.
  • LaNova Medicines — LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Show all investments...

K2VC
VC Fund · Beijing, Beijing, China · 12 investments in Asia Biotech startups

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

Show more...

Investment focus

  • Industry: E-Commerce, Manufacturing, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 181
  • Round size: Seed $1M–$14M; Angel $425k–$10M; Series A $1.4M–$24M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $141M in 2018

Portfolio highlights

  • Kewoke Technology — Kewo Ke Technology is a developer of diaphragms for hydrogen production via alkaline water electrolysis. It primarily develops diaphragms for alkaline water electrolysis, which are the building blocks of machines that produce hydrogen by alkaline water electrolysis. It is mostly used for site rental and employee pay, production line construction,laboratory construction, material purchasing, technology upgrading and transformation, and new product research and development.
  • Zhongling Xingneng — Zhongling Xingneng provides green energy services. It focuses on household photovoltaics and the topic of distributed photovoltaics. It delivers solutions for the whole life cycle of rooftop photovoltaic power plants, including investment, consultancy, design, building, operation, and maintenance, to residents and industrial and commercialcompanies. New energy ecological sectors, such as energy storage and wind power, will be developed in the future.
  • AndSolar Intelligent Technology — AndSolar Intelligent Technology focuses on to the development of system-level products, inverter systems, and MLPE equipment.
Show all investments...

Longpan Investment
VC Fund · Beijing, Beijing, China · 12 investments in Asia Biotech startups

Longpan Investment is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Cayman Islands

Investor stats

  • Total investments: 32
  • Round size: Seed $14M–$60M; Series A $14M–$28M; Series B $14M–$37M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Maibozhixing
  • Baiyi Pharmaceutical — Baiyi Pharmaceutical is a research-driven pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for neurological diseases, aiming to address unmet medical needs and improve patient outcomes.
  • BioTroy Therapeutics — BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.
Show all investments...

Keio Innovation Initiative
VC Fund · Tokyo, Tokyo, Japan · 12 investments in Asia Biotech startups

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: Japan, United Kingdom

Investor stats

  • Total investments: 81
  • Round size: Seed $1.5M–$213M; Series A $7.4M–$155M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
  • Aeterlink — Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power.
  • Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Show all investments...

Legend Star
VC Fund · Beijing, Beijing, China · 12 investments in Asia Biotech startups, 6 in the past 12 months

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, France

Investor stats

  • Total investments: 137
  • Round size: Seed $1.4M–$19M; Angel $425k–$7.1M; Series A $1.4M–$52M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $109M in 2018

Portfolio highlights

  • LyncBio Therapeutics
  • Beijing Anton Fusion — Beijing Anton Fusion is an innovative company that specializes in commercial power production technologies.
  • Booster Robotics — Accelerating Evolution is a humanoid robotics company. It provides humanoid robots to AI firms and research institutes, as well as quick mass production and supply of standard items.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Cowin Venture
VC Fund · Beijing, Beijing, China · 12 investments in Asia Biotech startups

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 97
  • Round size: Angel $425k–$1.4M; Series A $1.4M–$28M; Series B $2.8M–$257M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Furong Biotech — Furong Bio is a developer of innovative tumor immunology drugs.
  • Amador Bioscience — At Amador we provide global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
  • BioTroy Therapeutics — BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.
Show all investments...

Pan-Lin Capital
VC Fund · Shanghai, Shanghai, China · 12 investments in Asia Biotech startups, 8 in the past 12 months

Panlin Capital, following the investment theme of ‘consumption upgrade driven by technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors.As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors.Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Series B
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 73
  • Round size: Seed $1k–$28M; Series A $1.4M–$35M; Series B $7.1M–$57M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Dishi Medical — Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology.
  • LyncBio Therapeutics
  • Lingdong Core Optics — Lingdong Core Optics is a high-tech firm that specializes in the design and implementation of silicon-based integrated optoelectronic chips.
Show all investments...

Addor Capital
VC Fund · Nanjing, Jiangsu, China · 12 investments in Asia Biotech startups

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Electronics
  • Stage:Series A, Series B
  • Geography: China, Hong Kong, Singapore

Investor stats

  • Total investments: 298
  • Round size: Series A $1.4M–$28M; Series B $11M–$43M
  • Lead/follow: 51% lead, 49% follow

Portfolio highlights

  • Letuo Technology — Letuo Technology is a ASIC chip design & manufacturing firm focused on architecture and back end design, RTL coding, DFT, and synthesis.
  • Matrix Software — Matrix Software is a research organization that focuses on the analysis, management, and prevention of information technology risks.
  • Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
Show all investments...

ZSVC
VC Fund · Beijing, Beijing, China · 11 investments in Asia Biotech startups, 8 in the past 12 months

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, India

Investor stats

  • Total investments: 130
  • Round size: Seed $1.4M–$4M; Series A $1.4M–$16M; Series B $2.8M–$85M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Zhicheng AI — Zhicheng AI is a developer of general-purpose artificial intelligence robots, dedicated to designing and building intelligent robotic systems that integrate advanced AI algorithms, perception technologies, and adaptive learning capabilities
  • Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
  • Sunseeker — Sunseeker Power Equipment specializes in the manufacturing and supplying of garden tools, focusing on innovation in the realm of outdoor power equipment. The product range includes robotic lawn mowers, cordless Li-ion battery-powered tools, and petrol-powered equipment, catering to both garden and agricultural needs. The brand emphasizes onproviding solutions that enhance efficiency and ease of use in maintaining outdoor spaces. Sunseeker Power Equipment's offerings are designed to meet the demands of a global market, with a significant emphasis on exporting their products under the brand name 'SUNSEEKER 山科'. The company's portfolio extends to engines and a variety of garden tools series, showcasing a commitment to diversifying and expanding its product lineup to address the evolving needs of its customers.
Show all investments...

LYFE Capital
VC Fund · Shanghai, Shanghai, China · 11 investments in Asia Biotech startups

LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, France

Investor stats

  • Total investments: 79
  • Round size: Series A $11M–$85M; Series B $15M–$148M; Series C $6.5M–$142M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
  • Starna Therapeutics — Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.
  • ALLYRNA Pharmaceuticals — ALLYRNA, an innovative small molecule drug developer focused on first-in-class drug development, has established a unique platform for radiotherapy and immunotherapy sensitizers.
Show all investments...

ZhenFund
VC Fund · Beijing, Beijing, China · 11 investments in Asia Biotech startups

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, E-Commerce
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 369
  • Round size: Seed $650k–$20M; Angel $425k–$15M; Series A $1.4M–$28M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $130M in 2022

Portfolio highlights

  • 17zuoye — 17zuoye is an online learning platform for students K-12, as well as teachers and parents. The name means “homework together” in Chinese, and the site aims to serve as a nexus for all three groups to facilitate the educational experience, focusing on English and Math classes.17zuoye offers a multi-platform homework solution that is in sync withthe textbook curriculum and enhanced by big data analytics. 17zuoye provides the teachers with good teaching tools and comprehensive statistics, the students with interesting learning apps and individualized adaptive learning content, and the parents with immediate study reports. 17zuoye also acts as a social network for these users, having the largest real-name based online teachers’ forum and Wechat parent’s community in the country.
  • Virgin Hyperloop — Virgin Hyperloop is a developer of a transportation technology used to deliver fast, direct, and sustainable transportation at scale. Its technology is a first-generation vehicle system that makes trains go as fast as 760 miles per hour and utilizes a vacuum tube designed for transportation of people and cargo that enables companies to have directmovement of freight and people to travel quicker from origin to destination.It was founded in 2014 and is headquartered in Los Angeles, California.
  • Qingyue Technology — Qingyue Technology produces different versions of air disinfection machines and disinfection robots. Their products are intelligent anti-epidemic disinfection robots, air disinfection machines, and car air sterilisers. Their products are used in homes, hotels, banks, elevators, schools, hospitals, In indoor scenes such as airports, high-speed railstations, and shopping malls.
Show all investments...

JAFCO
VC Fund · Tokyo, Tokyo, Japan · 11 investments in Asia Biotech startups

Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: Japan, United States, Israel

Investor stats

  • Total investments: 271
  • Round size: Series A $2.7M–$255M; Series B $6.4M–$298M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Plott — Plott producing youtube animation platform under Vision “Become a Content holder from YouTube”. In August 2019, the company name was changed from Fabo to Plott. Plott, the new company name, is derived from the plot that you make before writing novels, etc., and the idea that “I want to make content all the time” is put in the company name.
  • Sharing Energy — Sharing Energy is providing energy supply and energy management services.
  • The Chain Museum — The Chain Museum creates a platform for connecting individuals .
Show all investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 11 investments in Asia Biotech startups

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 232
  • Round size: Seed $2.9M–$73M; Series A $1.4M–$30M; Series B $2.9M–$100M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
  • Lightwheel — Light Wheel Intelligence is offers automated, physically precise and controllable, real and generalizable synthetic data solutions to build AI data infrastructure,
  • Photoacoustic Pharmaceuticals — Photoacoustic Pharmaceuticals is an innovative developer of photosensitizers and related products. It is committed to advancing the development of dynamic photoacoustic therapy.
Show all investments...

Shunwei Capital
VC Fund · Beijing, Beijing, China · 11 investments in Asia Biotech startups

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Internet
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 418
  • Round size: Series A $1.4M–$41M; Series B $8.2M–$50M; Series C $20M–$130M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2018

Portfolio highlights

  • CertiK — CertiK, the largest Web3 security service provider, uses AI and formal verification to protect and monitor smart contracts and protocols, securing the Web3 ecosystem.
  • Leqi Intelligent — Leqi Intelligent is specialized in research and development in the field of intelligent short-term transportation through AIoT intelligent interconnection, intelligent somatosensory interaction, intelligent robot technology, intelligent algorithms, electronic control, electric drive, battery BMS system, and industrial design.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Show all investments...

Sinovation Ventures
VC Fund · Beijing, Beijing, China · 11 investments in Asia Biotech startups

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Internet
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 256
  • Round size: Seed $1M–$9M; Series A $1.4M–$28M; Series B $10M–$110M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $203M in 2022

Portfolio highlights

  • ChengRui — ChengRui is a green energy integrated solution providing company.
  • Zhongke Yichuang — Zhongke Yichuang focuses on the development of automotive chips, power semiconductors and new energy vehicle controller systems.
  • HPC-AI Technology — HPC-AI Technology provides a cloud-based platform to enhance AI computations by increasing CPU and GPU processing speeds.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Asia Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists